Articles dans des revues avec comité de lecture (48)
48.
Berkenboom, G., Langer, I., Carpentier, Y., Grosfils, K., & Fontaine, J. (1997). Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism. Hypertension, 30(3 Pt 1), 371-376. Communications publiées lors de congrès ou colloques nationaux et internationaux (2)
1.
Levet, V., Rosiere, R., Hecq, J., Langer, I., Amighi, K., & Wauthoz, N. (2017). Tolerance of Cisplatin Dry Powders for Inhalation and Efficacy on an Orthotopic Grafted Lung Tumor Preclinical Model. In R. R. N. Dalby, J. Peart, J. D. Suman, P. M. Young, & D. Traini (Eds.), RDD Europe 2017 (pp. 335-340) Virginia, USA: Virginia Commonwealth University. Participations à des congrès et colloques internationaux (2)
1.
Chraibi, S., Rosiere, R., De Prez, E., Langer, I., Nortier, J., Amighi, K., & Wauthoz, N. (2021). Evaluation of pulmonary and renal tolerance on mice of a cisplatin-based dry powder for inhalation to treat lung cancer. Poster présenté à la conférence Pharmaceutics, Biopharmaceutis and Pharmaceutical Technology (12th: 11-14th May 2021: Digital).2.
Rosiere, R., Van Woensel, M., Langer, I., Mathieu, V., Amighi, K., & Wauthoz, N. (2015). Nanomicelle-based dry powders for inhalation for targeted delivery to lung cancer cells: in vitro evaluation and in vivo local pulmonary tolerance on healthy mice. Poster présenté à la conférence European Conference on Pharmaceutics (1st: 13 and 14/04/2015: Reims, France). Thèses et mémoires (1)
Direction de thèses (1)
Participation aux jurys de thèse (7)